Return On Equity	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022	(Jun 30 2021) 2021	(Jun 30 2020) 2020
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

NXEN all Ratios >> Back to NXEN Management Effectiveness >> See Quarterly NXEN Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Jun 30 2024) ROE detoriated to 66.19 %, despite net income growth.

Financial Statements
Nexien Biopharma Inc 's Equity	$ 0 Millions	Annual NXEN's Balance sheet
Nexien Biopharma Inc 's Annual Income	$ 0 Millions	Annual NXEN's Income Statement
Where are NXEN's Income coming from?		Visit NXEN's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.